Exploiting tumour hypoxia in cancer treatment - PubMed (original) (raw)

Review

doi: 10.1038/nrc1367.

Affiliations

• PMID: 15170446
• DOI: 10.1038/nrc1367

Review

Exploiting tumour hypoxia in cancer treatment

J Martin Brown et al. Nat Rev Cancer. 2004 Jun.

No abstract available

PubMed Disclaimer

Similar articles

• The role of hypoxia-induced factors in tumor progression.
  Vaupel P. Vaupel P. Oncologist. 2004;9 Suppl 5:10-7. doi: 10.1634/theoncologist.9-90005-10. Oncologist. 2004. PMID: 15591418 Review.
• Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapy.
  Ingram N, Porter CD. Ingram N, et al. Gene Ther. 2005 Jul;12(13):1058-69. doi: 10.1038/sj.gt.3302504. Gene Ther. 2005. PMID: 15800661
• Targeting the molecular basis for tumour hypoxia.
  Carroll VA, Ashcroft M. Carroll VA, et al. Expert Rev Mol Med. 2005 Apr 15;7(6):1-16. doi: 10.1017/S1462399405009117. Expert Rev Mol Med. 2005. PMID: 15831177 Review.
• Hypoxia-inducible factors and hypoxic cell death in tumour physiology.
  Bacon AL, Harris AL. Bacon AL, et al. Ann Med. 2004;36(7):530-9. doi: 10.1080/07853890410018231. Ann Med. 2004. PMID: 15513303 Review.
• The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor alpha.
  Willam C, Nicholls LG, Ratcliffe PJ, Pugh CW, Maxwell PH. Willam C, et al. Adv Enzyme Regul. 2004;44:75-92. doi: 10.1016/j.advenzreg.2003.11.017. Adv Enzyme Regul. 2004. PMID: 15581484 Review. No abstract available.

Cited by

• Oral Hydrogels that Balance Microbiome for Tumor Treatment.
  Jiang C, Liu H, Zhang Y. Jiang C, et al. Research (Wash D C). 2024 Oct 2;7:0494. doi: 10.34133/research.0494. eCollection 2024. Research (Wash D C). 2024. PMID: 39371689 Free PMC article.
• Treating Deep-Seated Tumors with Radiodynamic Therapy: Progress and Perspectives.
  Zhu S, Lin S, Han R. Zhu S, et al. Pharmaceutics. 2024 Aug 28;16(9):1135. doi: 10.3390/pharmaceutics16091135. Pharmaceutics. 2024. PMID: 39339173 Free PMC article. Review.
• Nanotechnology based gas delivery system: a "green" strategy for cancer diagnosis and treatment.
  Chen M, Xu T, Song L, Sun T, Xu Z, Zhao Y, Du P, Xiong L, Yang Z, Jing J, Shi H. Chen M, et al. Theranostics. 2024 Aug 26;14(14):5461-5491. doi: 10.7150/thno.98884. eCollection 2024. Theranostics. 2024. PMID: 39310098 Free PMC article. Review.
• Inhibition of nucleo-cytoplasmic proteasome translocation by the aromatic amino acids or silencing Sestrin3-their sensing mediator-is tumor suppressive.
  Livneh I, Fabre B, Goldhirsh G, Lulu C, Zinger A, Shammai Vainer Y, Kaduri M, Dahan A, Ziv T, Schroeder A, Ben-Neriah Y, Zohar Y, Cohen-Kaplan V, Ciechanover A. Livneh I, et al. Cell Death Differ. 2024 Oct;31(10):1242-1254. doi: 10.1038/s41418-024-01370-x. Epub 2024 Sep 12. Cell Death Differ. 2024. PMID: 39266717 Free PMC article.
• Theranostic Diagnostics.
  Ali MU, Chaudhary BN, Panja S, Gendelman HE. Ali MU, et al. Results Probl Cell Differ. 2024;73:551-578. doi: 10.1007/978-3-031-62036-2_22. Results Probl Cell Differ. 2024. PMID: 39242393 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information